Health Advisers Revive Merck's Vioxx (Reuters)


Reuters - Merck & Co. Inc.'s
withdrawn arthritis drug Vioxx may return to the market after
U.S. health advisers narrowly voted it was safe enough to be
sold despite an increased risk of heart attack and stroke.

Read more...